Trisomy E (18) syndrome is associated with an extra number 18 chromosome, and though many of these patients can be readily recognized by their constellation of congenital defects, a chromosome analysis is usually required for confirmation. Because chromosome analysis still remains a fairly slow, expensive, and tedious examination, one purpose of the present study is to evaluate blood cell enzymes as a potential alternative approach to laboratory verification of clinical diagnosis. Secondly, it is believed that such studies in affected patients could aid in genetic linkage and chromosome mapping studies through correlation of changes in gene products, i.e. enzymes, with the chromosomal derangement. The results and interpretation of several blood cell enzyme studies in 5 patients with the trisomy E syndrome are presented.
Material and Methods
Five infants with clinical and chromosomal trisomy E syndrome were studied. The pertinent clinical findings which indicate this diagnosis in each patient are listed in Table I . There was no reason to suspect Rh or ABO incompatibility at the time of birth, but this was not further evaluated in any of the patients. The controls were approximately age-matched patients in hospital, who were not anaemic and did not have a chromosomal disorder.
Routine haematological studies were performed by standard methods. Chromosome analyses were performed on peripheral blood according to the method of Tanaka, Valentine, and Miwa (1962) , Koutras et al. (1964) , Schneider et al. (1965) , and Valentine et al. (1967) .
The leucocyte alkaline phosphatase was determined biochemically by the method described by Valentine and Beck (1951) , and histochemically by a modification of the procedures described by Wachstein (1946) (Table III) indicates that, with the exception of one patient, the hexokinase activity in the trisomy E patients is considerably higher than in the age-matched controls, and does not fall towards the normal adult values with increasing age as in the controls. However, a slight to moderate reticulocytosis is present in some of these patients compared with normal controls, and this enzyme is usually disproportionately raised in very young cells. The values for several enzymes in both the trisomy E patients and the controls tend to be higher than the normal adult values, but the enzyme activities in the trisomy E patients are, in general, slightly higher than in the age-matched controls. An unexplained low value for phosphofructokinase is noted in N.G.
The leucocyte enzyme values in both the trisomy E patients and controls tend to be similar to the adult controls for most enzymes (Table IV) . In contrast to the erythrocytes, the leucocyte hexokinase increased to normal adult values with increasing age in the trisomic patients. In general, the leucocyte enzyme values found in the trisomy E patients are similar or slightly decreased compared to the age-matched controls. There is no apparent reason for the slightly low values for the alkaline phosphatase assays in the age-matched controls from age 21 weeks to 11 weeks. Further, the low values in G.H. for glucose-6-phosphate dehydrogenase, phosphofructokinase, and phosphoglyceromutase, and the low value in C.C. for phosphopyruvate hydratase are unexplained, but, since this pattern is not seen in the other four trisomic patients, it is probably not related to the trisomic state.
Discussion
One purpose of the blood cell enzyme studies in the trisomy E (18) patients was to attempt localization of specific genes to the number 18 chromosome. This approach is based on two generally accepted genetic concepts. The first is that genes control cell metabolism through the formation of enzymes, the 'one gene-one enzyme' concept. The second is the 'gene dose effect' in which each allelic structural gene contributes quantitatively to the gene product (Harris, 1964) . Normally, there are two allelic genes at an autosomal locus in humans. Thus, two genes determine the enzyme activity which normally can be considered to be 100%, with 50%
contributed by each member of the allelic gene pair. In the trisomic state, the genes of the affected chromosome are present in triplicate. Based on the 'gene dose effect', each of the 3 allelic genes theoretically contribute 50% of normal activity resulting in 150% total activity or 5000 above normal in the trisomic state. Therefore, the activity of certain enzymes may reflect the number of genes controlling 
